Kolexia
Sesques Pierre Oncologie hémato.
Sesques Pierre
Oncologie hémato.
Hôpital Lyon Sud
Pierre-Bénite, France
117 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Lymphome B Lymphome B diffus à grandes cellules COVID-19 Myélome multiple Récidive tumorale locale Syndrome de libération de cytokines Tumeurs hématologiques Lymphome folliculaire

Collaborateurs

Voir plus
Bachy Emmanuel
Bachy Emmanuel
Hôpital Lyon Sud, Pierre-Bénite, France
Ferrant Emmanuelle
Ferrant Emmanuelle
Hôpital Lyon Sud, Pierre-Bénite, France
Ghesquieres Herve
Ghesquieres Herve
Hôpital Lyon Sud, Pierre-Bénite, France
Salles Gilles
Salles Gilles
Hôpital Lyon Sud, Pierre-Bénite, France

Industries

Voir plus
Gilead
37 collaboration(s)
Dernière en 2023
A+A
34 collaboration(s)
Dernière en 2023
Janssen
22 collaboration(s)
Dernière en 2023
B3TSI
20 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Treatment by a Bispecific CD3xCD20 Antibody for Relapse/Refractory Lymphomas After CAR T-cells Therapy: A Phase II Trial Evaluating Glofitamab, a Bispecific CD3xCD20 Antibody for Relapse/Refractory Lymphomas After CAR T-cells Therapy
Essai Clinique (The Lymphoma Academic Research Organisation)   04 décembre 2023
Retrospective multicenter comparative study of the efficacy and safety between R-DHAC and R-DHAOx in diffuse large B-cell lymphoma or transformed follicular or marginal zone B lymphoma into aggressive lymphoma, as a second-line treatment.
Leukemia & lymphoma   15 novembre 2023
Glofitamab Monotherapy in Patients with Non-Hodgkin B-Cell Lymphoma after Failing CAR T-Cell Infusion: Primary Analysis of the Bicar Study, a Phase II Lysa Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
Synthetic Control Arm from Clinical Trials and Real-World Data from Lysa Group for Untreated Diffuse Large B Cell Lymphoma Patients Aged over 80 Years: A Bona Fide Strategy for Innovative Clinical Trials
65th ASH Annual Meeting Abstracts   02 novembre 2023
The Post-CAR Prognostic Index (PC-PI): A New Prognostic Score to Predict Overall Survival in Large B-Cell Lymphoma Patients Progressing after Chimeric Antigen Receptor T-Cell Therapy
65th ASH Annual Meeting Abstracts   02 novembre 2023
A Genomic Approach for High-Grade B Cell Lymphoma with MYC and BCL2 and / or BCL6 Rearrangements: Two Clusters Stood out on Next Generation Sequencing Results
65th ASH Annual Meeting Abstracts   02 novembre 2023
Low Tmtv Influences Response and Outcomes in R/R DLBCL 3L+ Patients Treated with CAR-T Cells : First Results of FDG-PET/CT Analysis in the French Descar-T Registry
65th ASH Annual Meeting Abstracts   02 novembre 2023
Skeletal Muscle Index, As a Measure of Muscle Mass, Is a Significant Prognostic Factor for Newly Diagnosed Diffuse Large B-Cell Primary CNS Lymphoma Patients
65th ASH Annual Meeting Abstracts   02 novembre 2023
Nonrelapse mortality after CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry.
Blood advances   01 novembre 2023
High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma.
Blood advances   20 octobre 2023